Bronchodilator responsiveness: Interpret with caution

Thorax

Volumn 67, Issue 8, 2012, Pages 667-668

  Fingleton, James ^a   Weatherall, Mark ^b   Beasley, Richard ^a  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; LONG ACTING DRUG; SALBUTAMOL;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATOR RESPONSIVENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FLOW VOLUME CURVE; LUNG FUNCTION TEST; MAINTENANCE THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 84864008138     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201966     Document Type: Editorial

References (13)

1. The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2011. http://www.ginasthma.org
2. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A national clinical guideline. Thorax 2008;63:(Suppl IV): i16-18.
3. Tan W, Vollmer W, Lamprecht B, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease (BOLD) Study. Thorax 2012;67:718-26.
4. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. (Pubitemid 41632054)
5. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992;47:429-36.
6. Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest 1994;105:1042-5. (Pubitemid 24112787)
7. Richter DC, Joubert JR, Nell H, et al. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chron Obstruct Pulmon Dis 2008;3:693-9.
8. Anthonisen NR, Lindgren PG, Tashkin DP, et al. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 2005;26:45-51. (Pubitemid 40945930)
9. Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-64. (Pubitemid 36976273)
10. Hanania NA, Celli B, Donohue JF, et al. Bronchodilator reversibility in COPD. Chest 2011;140:1055-63.
11. Travers J, Marsh S, Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007;62:219-23.
12. Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med 2007;101:1313-20. (Pubitemid 46667661)
13. Postma DS, Brusselle G, Bush A, et al. I have taken my umbrella, so of course it does not rain. Thorax 2012;67:88-9.